The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
NK cells switch from granzyme B to death receptor–mediated cytotoxicity during serial killing
Open accessAbstract
NK cells eliminate virus-infected and tumor cells by releasing cytotoxic granules containing granzyme B (GrzB) or by engaging death receptors that initiate caspase cascades. The orchestrated interplay between both cell death pathways remains poorly defined. Here we simultaneously measure the activities of GrzB and caspase-8 in tumor cells upon contact with human NK cells. We observed that NK cells switch from inducing a fast GrzB-mediated cell death in their first killing events to a slow death receptor–mediated killing during subsequent tumor cell encounters. Target cell contact reduced intracellular GrzB and perforin and increased surface-CD95L in NK cells over time, showing how the switch in cytotoxicity pathways is controlled. Without perforin, NK cells were unable to perform GrzB-mediated serial killing and only killed once via death receptors. In contrast, the absence of CD95 on tumor targets did not impair GrzB-mediated serial killing. This demonstrates that GrzB and death receptor–mediated cytotoxicity are differentially regulated during NK cell serial killing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
Nivolumab plus Ipilimumab in Advanced Melanoma
Wolchok, J. D., Kluger, H., Callahan, M. K., Postow, M. A., Rizvi, N. A., Lesokhin, A. M., Segal, N. H., Ariyan, C. E., Gordon, R.-A., Reed, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1302369 · Cited by 4,230
Car t cell immunotherapy for human cancer
June, C. H., O’Connor, R. S., Kawalekar, O. U., Ghassemi, S., & Milone, M. C. (2018) · Science · doi:10.1126/science.aar6711 · Cited by 3,207
Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
Wang, Y., Gao, W., Shi, X., Ding, J., Liu, W., He, H., Wang, K., & Shao, F. (2017) · Nature · doi:10.1038/nature22393 · Cited by 3,199
Curran, M. A., Montalvo, W., Yagita, H., & Allison, J. P. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0915174107 · Cited by 1,874
Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated Cytotoxicity
Kägi, D., Vignaux, F., Ledermann, B., Bürki, K., Depraetere, V., Nagata, S., Hengartner, H., & Golstein, P. (1994) · Science · doi:10.1126/science.7518614 · Cited by 1,516
Rogers, C., Fernandes-Alnemri, T., Mayes, L., Alnemri, D., Cingolani, G., & Alnemri, E. S. (2017) · Nature Communications · doi:10.1038/ncomms14128 · Cited by 1,510 · cited 1×
“This could be due to an induction of pyroptosis mediated by activated caspase-3 as previously reported (Rogers et al., 2017; Wang et al., 2017).”
Imai, K., Matsuyama, S., Miyake, S., Suga, K., & Nakachi, K. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03231-1 · Cited by 1,190
FLICE is activated by association with the CD95 death-inducing signaling complex (DISC)
Medema, J. P. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2794 · Cited by 1,188
CD8+ T Cells: Foot Soldiers of the Immune System
Zhang, N., & Bevan, M. J. (2011) · Immunity · doi:10.1016/j.immuni.2011.07.010 · Cited by 1,088
The CD95(APO-1/Fas) DISC and beyond
Peter, M. E., & Krammer, P. H. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401186 · Cited by 1,080
Targeting natural killer cells in cancer immunotherapy
Guillerey, C., Huntington, N. D., & Smyth, M. J. (2016) · Nature Immunology · doi:10.1038/ni.3518 · Cited by 1,066
The many roles of FAS receptor signaling in the immune system
Strasser, A., Jost, P. J., & Nagata, S. (2009) · Immunity · doi:10.1016/j.immuni.2009.01.001 · Cited by 968
Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity.
Rouvier, E., Luciani, M. F., & Golstein, P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.1.195 · Cited by 787
Death by a Thousand Cuts: Granzyme Pathways of Programmed Cell Death
Chowdhury, D., & Lieberman, J. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090404 · Cited by 700
Mechanisms of natural killer cell-mediated cellular cytotoxicity
Prager, I., & Watzl, C. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.mr0718-269r · Cited by 627
Self-citationNatural killer cell memory in infection, inflammation and cancer
Cerwenka, A., & Lanier, L. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.9 · Cited by 576
Hemophagocytic Lymphohistiocytosis
Al-Samkari, H., & Berliner, N. (2018) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043625 · Cited by 506
Emerging insights into natural killer cells in human peripheral tissues
Björkström, N. K., Ljunggren, H.-G., & Michaëlsson, J. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.34 · Cited by 449
The human natural killer cell immune synapse
Davis, D. M., Chiu, I., Fassett, M., Cohen, G. B., Mandelboim, O., & Strominger, J. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15062 · Cited by 416
The structural basis for membrane binding and pore formation by lymphocyte perforin
Law, R. H. P., Lukoyanova, N., Voskoboinik, I., Caradoc-Davies, T. T., Baran, K., Dunstone, M. A., D’Angelo, M. E., Orlova, E. V., Coulibaly, F., Verschoor, S., et al. (2010) · Nature · doi:10.1038/nature09518 · Cited by 414
Sutton, V. R., Davis, J. E., Cancilla, M., Johnstone, R. W., Ruefli, A. A., Sedelies, K., Browne, K. A., & Trapani, J. A. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.10.1403 · Cited by 386
New Paradigm for Lymphocyte Granule-mediated Cytotoxicity
Froelich, C. J., Orth, K., Turbov, J., Seth, P., Gottlieb, R., Babior, B., Shah, G. M., Bleackley, R. C., Dixit, V. M., & Hanna, W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29073 · Cited by 358
Barry, M., Heibein, J. A., Pinkoski, M. J., Lee, S.-F., Moyer, R. W., Green, D. R., & Bleackley, R. C. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.3781-3794.2000 · Cited by 345
Andrade, F., Roy, S., Nicholson, D., Thornberry, N., Rosen, A., & Casciola-Rosen, L. (1998) · Immunity · doi:10.1016/s1074-7613(00)80550-6 · Cited by 325
Thiery, J., Keefe, D., Boulant, S., Boucrot, E., Walch, M., Martinvalet, D., Goping, I. S., Bleackley, R. C., Kirchhausen, T., & Lieberman, J. (2011) · Nature Immunology · doi:10.1038/ni.2050 · Cited by 314
Secretory Mechanisms in Cell-Mediated Cytotoxicity
Stinchcombe, J. C., & Griffiths, G. M. (2007) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.23.090506.123521 · Cited by 312
Mechanisms and dynamics of T cell-mediated cytotoxicity in vivo
Halle, S., Halle, O., & Förster, R. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.04.002 · Cited by 302 · cited 1×
“The most effective mediators of cellular cytotoxicity are CD8+ CTLs and natural killer (NK) cells (Zhang and Bevan, 2011; Cerwenka and Lanier, 2016; Halle et al., 2017).”
BackgroundNatural killer cell-mediated immunosurveillance of human cancer
Malmberg, K.-J., Carlsten, M., Björklund, A., Sohlberg, E., Bryceson, Y. T., & Ljunggren, H.-G. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.002 · Cited by 299
Serial Killing of Tumor Cells by Human Natural Killer Cells – Enhancement by Therapeutic Antibodies
Bhat, R., & Watzl, C. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000326 · Cited by 286
Self-citationAn early history of T cell-mediated cytotoxicity
Golstein, P., & Griffiths, G. M. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0009-3 · Cited by 284
Lopez, J. A., Susanto, O., Jenkins, M. R., Lukoyanova, N., Sutton, V. R., Law, R. H. P., Johnston, A., Bird, C. H., Bird, P. I., Whisstock, J. C., et al. (2013) · Blood · doi:10.1182/blood-2012-07-446146 · Cited by 262
Human NK cell lytic granules and regulation of their exocytosis
Krzewski, K., & Coligan, J. E. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00335 · Cited by 229
Isaaz, S., Baetz, K., Olsen, K., Podack, E., & Griffiths, G. M. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250432 · Cited by 228
Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering
Daher, M., & Rezvani, K. (2018) · Current Opinion in Immunology · doi:10.1016/j.coi.2018.03.013 · Cited by 224
Cell biological steps and checkpoints in accessing NK cell cytotoxicity
Mace, E. M., Dongre, P., Hsu, H., Sinha, P., James, A. M., Mann, S. S., Forbes, L. R., Watkin, L. B., & Orange, J. S. (2014) · Immunology & Cell Biology · doi:10.1038/icb.2013.96 · Cited by 218
Regulation of cell surface APO‐1/Fas (CD95) ligand expression by metalloproteases
Mariani, S. M., Matiba, B., Bäumler, C., & Krammer, P. H. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250828 · Cited by 217
Mariani, S. M., & Krammer, P. H. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199803)28:03<973::aid-immu973>3.0.co;2-t · Cited by 205
Classification of human natural killer cells based on migration behavior and cytotoxic response
Vanherberghen, B., Olofsson, P. E., Forslund, E., Sternberg-Simon, M., Khorshidi, M. A., Pacouret, S., Guldevall, K., Enqvist, M., Malmberg, K.-J., Mehr, R., et al. (2013) · Blood · doi:10.1182/blood-2012-06-439851 · Cited by 196
Self-citationProteolytic activation of the cell death protease Yama/CPP32 by granzyme B.
Quan, L. T., Tewari, M., O'Rourke, K., Dixit, V, Snipas, S. J., Poirier, G. G., Ray, C., Pickup, D. J., & Salvesen, G. S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.1972 · Cited by 172
Srpan, K., Ambrose, A., Karampatzakis, A., Saeed, M., Cartwright, A. N. R., Guldevall, K., De Matos, G. D. S. C., Önfelt, B., & Davis, D. M. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201712085 · Cited by 169
Self-citationSurface CD107a/LAMP-1 protects natural killer cells from degranulation-associated damage
Cohnen, A., Chiang, S. C., Stojanovic, A., Schmidt, H., Claus, M., Saftig, P., Janßen, O., Cerwenka, A., Bryceson, Y. T., & Watzl, C. (2013) · Blood · doi:10.1182/blood-2012-07-441832 · Cited by 160
Self-citationZagury, D., Bernard, J., Thierness, N., Feldman, M., & Berke, G. (1975) · European Journal of Immunology · doi:10.1002/eji.1830051205 · Cited by 157
Cazaux, M., Grandjean, C. L., Lemaı̂tre, F., Garcia, Z., Beck, R. J., Milo, I., Postat, J., Beltman, J. B., Cheadle, E. J., & Bousso, P. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20182375 · Cited by 152
Hassin, D., Garber, O. G., Meiraz, A., Schiffenbauer, Y. S., & Berke, G. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03426.x · Cited by 143
Remodeling of secretory lysosomes during education tunes functional potential in NK cells
Goodridge, J. P., Jacobs, B., Sætersmoen, M., Clement, D., Hammer, Q., Clancy, T., Skarpen, E., Brech, A., Landskron, J., Grimm, C. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08384-x · Cited by 140
Imaging burst kinetics and spatial coordination during serial killing by single natural killer cells
Choi, P. J., & Mitchison, T. J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221312110 · Cited by 133
Natural killer cell immunotherapies against cancer: checkpoint inhibitors and more
Chiossone, L., Vienne, M., Kerdiles, Y. M., & Vivier, É. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.003 · Cited by 121
Single Degranulations in NK Cells Can Mediate Target Cell Killing
Gwalani, L. A., & Orange, J. S. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701500 · Cited by 112
Urlaub, D., Höfer, K., Müller, M., & Watzl, C. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601004 · Cited by 110
Self-citationBackes, C. S., Friedmann, K. S., Mang, S., Knörck, A., Hoth, M., & Kummerow, C. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004549 · Cited by 107
Cyclic Luciferase for Real‐Time Sensing of Caspase‐3 Activities in Living Mammals
Kanno, A., Yamanaka, Y., Hirano, H., Umezawa, Y., & Ozawa, T. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200700538 · Cited by 104
Moroso, V., Metselaar, H. J., Mancham, S., Tilanus, H. W., Eissens, D., van der Meer, A., van der Laan, L. J. W., Kuipers, E. J., Joosten, I., & Kwekkeboom, J. (2010) · Liver Transplantation · doi:10.1002/lt.22080 · Cited by 92
Caspase-8 cleaves its substrates from the plasma membrane upon CD95-induced apoptosis
Beaudouin, J., Liesche, C., Aschenbrenner, S., Hörner, M., & Eils, R. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2012.156 · Cited by 89
Self-citationZhu, Y., Huang, B. Y., & Shi, J. (2016) · Oncotarget · doi:10.18632/oncotarget.9980 · Cited by 83
Watzl, C. (2014) · Advances in immunology · doi:10.1016/b978-0-12-800147-9.00005-4 · Cited by 82
Self-citationGranzyme B Activity in Target Cells Detects Attack by Cytotoxic Lymphocytes
Packard, B. Z., Telford, W. G., Komoriya, A., & Henkart, P. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.3812 · Cited by 74
Imaging Immune Surveillance of Individual Natural Killer Cells Confined in Microwell Arrays
Guldevall, K., Vanherberghen, B., Frisk, T. W., Hurtig, J., Christakou, A. E., Manneberg, O., Lindström, S., Svahn, H. A., Wiklund, M., & Önfelt, B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015453 · Cited by 72
Self-citationTermination of the Activating NK Cell Immunological Synapse Is an Active and Regulated Process
Netter, P., Anft, M., & Watzl, C. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700394 · Cited by 56
Self-citationLi, J., Rosen, D., Sondel, P. M., & Berke, G. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01380.x · Cited by 43
Frisk, T. W., Khorshidi, M. A., Guldevall, K., Vanherberghen, B., & Önfelt, B. (2011) · Biomedical Microdevices · doi:10.1007/s10544-011-9538-2 · Cited by 39
Self-citationLi, J., Figueira, S. K., Vrazo, A. C., Binkowski, B. F., Butler, B. L., Tabata, Y., Filipovich, A. H., Jordan, M. B., & Risma, K. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301668 · Cited by 36
Schmidt, H., Gelhaus, C., Nebendahl, M., Lettau, M., Watzl, C., Kabelitz, D., Leippe, M., & Janßen, O. (2008) · PROTEOMICS · doi:10.1002/pmic.200800170 · Cited by 36
Self-citationForslund, E., Guldevall, K., Olofsson, P. E., Frisk, T., Christakou, A., Wiklund, M., & Önfelt, B. (2012) · Front. Immun. · doi:10.3389/fimmu.2012.00300 · Cited by 35
Self-citationKassahn, D., Nachbur, U., Conus, S., Micheau, O., Schneider, P., Simon, H.-U., & Brunner, T. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.133 · Cited by 31
Fasbender, F., Claus, M., Wingert, S., Sandusky, M., & Watzl, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00789 · Cited by 29
Self-citationVrazo, A. C., Hontz, A. E., Figueira, S. K., Butler, B. L., Ferrell, J. M., Binkowski, B. F., Li, J., & Risma, K. (2015) · Blood · doi:10.1182/blood-2015-03-632273 · Cited by 28
Liesche, C., Sauer, P., Prager, I., Urlaub, D., Claus, M., Eils, R., Beaudouin, J., & Watzl, C. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01840 · Cited by 25
Self-citation
Cited by
Exploring the NK cell platform for cancer immunotherapy
Myers, J. A., & Miller, J. S. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0426-7 · Cited by 1,276
NK cells for cancer immunotherapy
Shimasaki, N., Jain, A., & Campana, D. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0052-1 · Cited by 1,222
The cancer–natural killer cell immunity cycle
Huntington, N. D., Cursons, J., & Rautela, J. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-0272-z · Cited by 566
CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Peng, L., Sferruzza, G., Yang, L., Zhou, L., & Chen, S. (2024) · Cellular & Molecular Immunology · doi:10.1038/s41423-024-01207-0 · Cited by 373
Targeting cereblon in hematologic malignancies
Fuchs, O. (2023) · Blood Reviews · doi:10.1016/j.blre.2022.100994 · Cited by 55
Metadata
- Authors
- Prager, I., Liesche, C., van Ooijen, H., Urlaub, D., Verron, Q., Sandström, N., Fasbender, F., Claus, M., Eils, R., Beaudouin, J., Önfelt, B., & Watzl, C.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2019-07-03
- Volume
- 216
- Issue
- 9
- Pages
- 2113-2127
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2956050946
- Cited by
- 374
- References
- 68
- FWCI
- 11.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.